VR Logo

Glaxosmithkline Pharmaceuticals Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

Get the Stocks!

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1924

Chairman: R S Karnad

Managing Director: S Venkatesh

Group: Glaxosmithkline - MNC

Listing: NSE: GLAXO, BSE: 500660

Headquarters: Mumbai, Maharashtra

Website: www.gsk-india.com

Key Facts

Market cap: R 24,860.34 Cr

Revenue (TTM): R 3,082.30 Cr

Earnings (TTM): R -335.79 Cr

Cash: R 1,083.20 Cr

Total Debt: R 0.18 Cr

Promoters' ownership: 75.00%

Liquidity: High

52 Week range: R 962.65 - 1,807.50

Face value: R10.00

Shares outstanding: 16,94,06,034

10 Years Aggregate:

  • CFO: 3,493.33 Cr
  • EBITDA: 5,930.02 Cr
  • Net Profit: 4,129.09 Cr

Stock Performance

Time Period Glaxosmithkline Pharma S&P BSE Healthcare* S&P BSE Mid Cap*
YTD-9.63-0.693.38
1 month-4.24-0.394.93
3 months-1.889.6523.85
1 Year-12.3952.2617.12
3 Years5.9512.721.30
5 Years-1.906.5212.65
10 Years2.7612.809.88
As on 27-Jan-2021 *As on 25-Jan-2021
Year Glaxosmithkline Pharma S&P BSE Mid Cap S&P BSE Healthcare
2020-0.4819.8761.45
20197.50-3.05-3.55
201821.62-13.31-5.89
2017-8.8148.130.49
2016-17.157.97-12.88
20154.557.4315.06
20146.9654.6947.43